4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cocrystal Pharma, Inc. (COCP) operates in the Biotechnology industry and is headquartered in Bothell, United States with about 10 employees. Its market capitalization is roughly $13 million. In the fiscal year ended 2025-12-31, COCP reported $0M in revenue and ($9M) in net income.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
Interactive charts & full statements → Open the COCP valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($18M) | ($21M) | ($18M) | — |
| Net Income | ($9M) | ($18M) | ($18M) | ($39M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $10M | $14M | $31M | $41M | — |
| Total Liabilities | $3M | $4M | $5M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive COCP viewer.
About TickerBase · Data methodology & sources